Test Price
2,800 AED✅ Home Collection Available
MKKS Gene Bardet-Biedl Syndrome Type 6 Genetic Testing in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجينات MKKS لمتلازمة بارديت-بيديل النوع السادس في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يقدم هذا التحليل الجيني المتطور تشخيصًا دقيقًا لمتلازمة بارديت-بيديل من النوع السادس عبر تقنية التسلسل الجيني (NGS) وفقًا لأحدث معايير هيئة الصحة بدبي، مع ضمان سرية البيانات ودعم استشاري متكامل.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Result Interpretation by DHA-Licensed Genetic Counsellors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
1. Overview: What Is the MKKS Bardet-Biedl Syndrome Type 6 Test?
This Next-Generation Sequencing (NGS) test analyses the entire coding region of the MKKS gene to detect pathogenic variants causing Bardet-Biedl Syndrome type 6, a ciliopathy associated with retinal dystrophy, polydactyly, obesity, renal anomalies, and hypogonadism. (هذا التحليل يفحص الجين MKKS بالكامل لتشخيص متلازمة بارديت-بيديل النوع السادس، وهو اضطراب وراثي نادر.)
| Feature | Our Test (2026 DHA-Standard) | Closest Alternative |
|---|---|---|
| Methodology | NGS – Full gene sequencing (exons + splice sites) | Targeted mutation panel / single-site analysis |
| Clinical Sensitivity | >99% for MKKS point mutations & small indels | Limited to known familial variants (~70% in some panels) |
| Turnaround Time | 3–4 Weeks | Often 5–6 Weeks |
| UAE Compliance | Full DHA/MOHAP & ISO 9001:2015 | Varies; may lack local accreditation |
| Post-Test Support | Bilingual genetic counselling & physician teleconsultation | Typically report-only |
2. Clinical Insight & Safety Protocol
“As a clinician, I understand that undergoing genetic testing for a rare syndrome like Bardet-Biedl can be emotionally challenging. This test provides vital molecular confirmation that guides multidisciplinary management – from renal monitoring to visual rehabilitation – and must always be interpreted alongside a detailed phenotype and family history.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Senior Consultant Geneticist.
⚠️ Medication & Safety Notice
Do not discontinue any prescribed medication without consulting your doctor. This test requires no specific medication adjustment. However, full clinical history and pre-test genetic counselling are mandatory to interpret results accurately.
🛑 Safety Exclusion Criteria & Red Flags
- Exclusion: Individuals unable to provide informed consent (unless via legal guardian as per UAE CDS Law 2026 for minors).
- Exclusion: Recent blood transfusion (<2 weeks) may affect DNA source if using FTA card – discuss with laboratory.
- Red Flag: If the patient exhibits acute renal failure, severe visual loss, or uncontrolled hypertension, prioritise urgent specialist referral; genetic testing remains elective.
- Red Flag: Any suspicion of child abuse/neglect as a contributor to clinical presentation must be reported per UAE mandatory safeguarding laws.
3. Patient FAQ & Clinical Guidance
Q1: Is the MKKS gene necessary if I already have a clinical diagnosis of Bardet-Biedl syndrome?
A: Yes, genetic confirmation identifies the specific MKKS variant, guides family member testing, and supports targeted management for renal and endocrine complications unique to type 6.
نعم، التأكيد الجيني يحدد الطفرة المحددة، ويساعد في فحص الأقارب، ويوجه الرعاية المتخصصة للمضاعفات الكلوية والغدد الصماء الخاصة بالنوع السادس.
Q2: What sample types are accepted, and how is the home collection arranged?
A: Whole blood, extracted DNA, or a single drop of blood on an FTA card can be used; our VIP mobile phlebotomy team collects at your preferred UAE location between 8 AM and 11 PM.
يمكن استخدام الدم الكامل، أو الحمض النووي المستخلص، أو بقعة دم على بطاقة FTA؛ فريقنا المتنقل يجمع العينة من منزلك في أي مكان بالإمارات من الثامنة صباحاً حتى الحادية عشرة مساءً.
Q3: Will my genetic data be kept confidential under UAE law?
A: Absolutely, all genetic information is protected by Federal Decree-Law No. 41 of 2024 and UAE PDPL, ensuring encrypted storage and access restricted to your designated healthcare professionals.
بالتأكيد، جميع البيانات الجينية محمية بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي، مع تخزين مشفر وصول مقصور على مقدمي الرعاية المحددين.
Regulatory Compliance & Authority
- Federal Decree-Law No. 41 of 2024 on Health and Patient Safety (Art. 87 – Genetic Testing Confidentiality & Consent).
- CDS Law 2026 (Minors) – Mandatory parental/guardian consent for individuals under 18 years.
- UAE PDPL (Federal Decree-Law No. 45 of 2021) – Data Privacy and Security.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
- DHA Facility License: 9834453.
- LOINC Code: 81247-7 (MKKS gene mutations found in Blood or Tissue by Sequencing).
- ICD-10-CM 2026: Q87.8 (Bardet-Biedl syndrome), Z14.8 (Genetic carrier), Z13.71 (Encounter for genetic testing).
Contact: +971 54 548 8731 (Support & WhatsApp) | Home Collection available 8 AM – 11 PM, 7 days a week.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians